Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Enhancing immunity to HIV through APOBEC.

Harris RS.

Nat Biotechnol. 2008 Oct;26(10):1089-90. doi: 10.1038/nbt1008-1089. No abstract available.

PMID:
18846074
2.

Small-molecule inhibition of HIV-1 Vif.

Nathans R, Cao H, Sharova N, Ali A, Sharkey M, Stranska R, Stevenson M, Rana TM.

Nat Biotechnol. 2008 Oct;26(10):1187-92. doi: 10.1038/nbt.1496. Epub 2008 Sep 21.

3.

HIV-1 Vif, APOBEC, and intrinsic immunity.

Goila-Gaur R, Strebel K.

Retrovirology. 2008 Jun 24;5:51. doi: 10.1186/1742-4690-5-51. Review.

4.

Natural resistance to HIV infection: The Vif-APOBEC interaction.

Malim MH.

C R Biol. 2006 Nov;329(11):871-5. Epub 2006 Aug 17.

PMID:
17067930
5.

Antiviral roles of APOBEC proteins against HIV-1 and suppression by Vif.

Romani B, Engelbrecht S, Glashoff RH.

Arch Virol. 2009;154(10):1579-88. doi: 10.1007/s00705-009-0481-y. Epub 2009 Aug 12. Review.

PMID:
19669862
6.

HIV-2 Vif Diversity Among Defective and Nondefective Sequences.

Bertine M, Visseaux B, Storto A, Collin G, Matheron S, Descamps D, Charpentier C; ANRS CO5 HIV-2 Cohort..

J Acquir Immune Defic Syndr. 2016 May 1;72(1):e9-e11. doi: 10.1097/QAI.0000000000000924. No abstract available.

PMID:
26689972
7.

HIV-1 Vif: counteracting innate antiretroviral defenses.

Cullen BR.

Mol Ther. 2003 Oct;8(4):525-7. No abstract available.

PMID:
14565218
8.

T cells target APOBEC3 proteins in human immunodeficiency virus type 1-infected humans and simian immunodeficiency virus-infected Indian rhesus macaques.

Champiat S, Garrison KE, Raposo RA, Burwitz BJ, Reed J, Tandon R, York VA, Newman LP, Nimityongskul FA, Wilson NA, Almeida RR, Martin JN, Deeks SG, Rosenberg MG, Wiznia AA, Spotts GE, Pilcher CD, Hecht FM, Ostrowski MA, Sacha JB, Nixon DF.

J Virol. 2013 Jun;87(11):6073-80. doi: 10.1128/JVI.00579-12. Epub 2013 Mar 27.

9.

Stably expressed APOBEC3F has negligible antiviral activity.

Miyagi E, Brown CR, Opi S, Khan M, Goila-Gaur R, Kao S, Walker RC Jr, Hirsch V, Strebel K.

J Virol. 2010 Nov;84(21):11067-75. doi: 10.1128/JVI.01249-10. Epub 2010 Aug 11.

10.

Retroviral restriction by APOBEC proteins.

Harris RS, Liddament MT.

Nat Rev Immunol. 2004 Nov;4(11):868-77. Review.

PMID:
15516966
11.

[Antiviral defense by APOBEC3 family proteins].

Takaori A.

Uirusu. 2005 Dec;55(2):267-72. Review. Japanese.

12.

[Advances in the study of molecular mechanism of APOBEC3G anti-HIV-1].

Fan B, Cen S, Jiang JD.

Yao Xue Xue Bao. 2008 Jul;43(7):678-82. Review. Chinese.

PMID:
18819469
13.

[How Vif regulates the infectivity of HIV-1].

Takaori-Kondo A.

Seikagaku. 2004 Dec;76(12):1569-73. Review. Japanese. No abstract available.

PMID:
15675371
14.

Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.

He Z, Zhang W, Chen G, Xu R, Yu XF.

J Mol Biol. 2008 Sep 12;381(4):1000-11. doi: 10.1016/j.jmb.2008.06.061. Epub 2008 Jun 28.

PMID:
18619467
15.

RNA and DNA binding properties of HIV-1 Vif protein: a fluorescence study.

Bernacchi S, Henriet S, Dumas P, Paillart JC, Marquet R.

J Biol Chem. 2007 Sep 7;282(36):26361-8. Epub 2007 Jul 2.

16.

APOBEC deaminases as cellular antiviral factors: a novel natural host defense mechanism.

Franca R, Spadari S, Maga G.

Med Sci Monit. 2006 May;12(5):RA92-8. Review.

PMID:
16641889
17.

CEM-T4 cells do not lack an APOBEC3G cofactor.

Haché G, Harris RS.

PLoS Pathog. 2009 Jul;5(7):e1000528. doi: 10.1371/journal.ppat.1000528. Epub 2009 Jul 31. No abstract available.

18.

APOBEC family proteins: novel antiviral innate immunity.

Takaori-Kondo A.

Int J Hematol. 2006 Apr;83(3):213-6. Review.

PMID:
16720550
19.

APOBEC-mediated viral restriction: not simply editing?

Holmes RK, Malim MH, Bishop KN.

Trends Biochem Sci. 2007 Mar;32(3):118-28. Epub 2007 Feb 15. Review.

PMID:
17303427
20.

[HIV-1, a very Vif virus].

Schwartz O.

Med Sci (Paris). 2004 Feb;20(2):139-41. French. No abstract available.

Supplemental Content

Support Center